12-10311559-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002262.5(KLRD1):c.259C>A(p.His87Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000136 in 1,614,080 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002262.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KLRD1 | NM_002262.5 | c.259C>A | p.His87Asn | missense_variant | 4/6 | ENST00000336164.9 | NP_002253.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KLRD1 | ENST00000336164.9 | c.259C>A | p.His87Asn | missense_variant | 4/6 | 1 | NM_002262.5 | ENSP00000338130 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152192Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000107 AC: 27AN: 251446Hom.: 0 AF XY: 0.0000957 AC XY: 13AN XY: 135894
GnomAD4 exome AF: 0.000142 AC: 208AN: 1461770Hom.: 0 Cov.: 31 AF XY: 0.000136 AC XY: 99AN XY: 727182
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152310Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74484
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 16, 2022 | The c.259C>A (p.H87N) alteration is located in exon 4 (coding exon 4) of the KLRD1 gene. This alteration results from a C to A substitution at nucleotide position 259, causing the histidine (H) at amino acid position 87 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at